Although the global digital transformation of health care has faced resistance, FCV has charted its own path toward a digital ...

Initiated IND-enabling toxicology program IND submission planned for 4Q25; Clinical data expected in 1H26 CRANBURY, N.J., March 25, 2025 /PRNewswire/ -- Palatin ...

Syncromune ® Inc., a clinical-stage biopharmaceutical company developing SYNC-T, an in situ personalized immunotherapy platform optimized for solid tumor cancers, today announced the appointment of ...

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that new findings from ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest dose cohort with no dose-limiting toxicities (DLTs), resu ...

Senior Vice President of Davis Health System and Chief Administrative Officer of Davis Medical Center (DMC) Ronald Andro, and ...

Work on new career ladders, reducing technology barriers, comprehensive space planning, enhancing educational efforts and ...

BDC-4182 on track to start a clinical trial in gastric cancer in second quarter 2025BDC-3042 Phase 1 clinical trial fully enrolled the highest ...

Rheumatologists and cardiologists have long co-managed patients out of necessity and without much formal collaboration or ...

The diabetes prediction system is designed to predict the risk of diabetes utilizing clinical and genetic information through deep learning artificial intelligence algorithms.